-
CEPI calls for proposals to apply for COVID-19 vaccine funding
europeanpharmaceuticalreview
May 08, 2020
CEPI has announced it is urging organisations to apply for funding for the development and manufacturing of potential COVID-19 vaccines.
-
CEPI and European Investment Bank collaborate to Fund Vaccine Projects
Europeanpharmaceuticalreview
May 07, 2020
The Coalition for Epidemic Preparedness Innovations (CEPI) and European Investment Bank (EIB) will work together to identify and fund vaccine projects for infectious diseases.
-
CEPI Inks COVID-19 Vax Pact with Clover Bio
contractpharma
May 05, 2020
Becomes ninth global COVID-19 vaccine development project that CEPI has signed since Jan 23, 2020.
-
EIB, CEPI Sign Agreement to Accelerate Infectious Disease Vaccination Development
americanpharmaceuticalreview
May 04, 2020
The Coalition for Epidemic Preparedness Innovations (CEPI) and the European Investment Bank (EIB) signed an advisory agreement to collaborate on the development of innovative financing schemes to support vaccines development across the globe.
-
Clover Biopharmaceuticals gets CEPI funding for Covid-19 vaccine
harmaceutical-technology
April 30, 2020
The Coalition for Epidemic Preparedness Innovations (CEPI) has signed an agreement with Clover Biopharmaceuticals Australia, a subsidiary of China-based Sichuan Clover Biopharmaceuticals, to support the development of a Covid-19 vaccine candidate.
-
UK pledges £210m to CEPI for Covid-19 vaccine development
pharmaceutical-technology
March 30, 2020
Non-profit the Coalition for Epidemic Preparedness Innovations (CEPI) has received £210m from the UK Government to support efforts to develop a Covid-19 vaccine.
-
Dynavax teams up with CEPI for Covid-19 vaccine
pharmaceutical-technology
March 30, 2020
Dynavax Technologies has partnered with the Coalition for Epidemic Preparedness Innovations (CEPI) to create a vaccine against Covid-19 infection.
-
CEPI finds eighth Covid-19 partner in Institut Pasteur
pharmaceutical-technology
March 23, 2020
The Norwegian Coalition for Epidemic Preparedness Innovations (CEPI) has made a $4.9m investment in a Covid-19 vaccine consortium led by the Paris-based Institut Pasteur.
-
CEPI calls for $2bn of funding for coronavirus vaccine
europeanpharmaceuticalreview
March 18, 2020
According to CEPI, $2 billion is needed to progress coronavirus vaccines through development as quickly as possible, leading the organisation to call for donations.
-
Novavax secures CEPI funding for Covid-19 vaccine
pharmaceutical-technology
March 12, 2020
Novavax has received initial funding of $4m from the Coalition for Epidemic Preparedness Innovations (CEPI) for the development of a Covid-19 vaccine.